NL-OMON46373已完成不适用
A double-blind, randomized, placebo-controlled, combined single and multiple ascending dose study to investigate the safety, tolerability and pharmacokinetic profile of AB928 in healthy volunteers. - AB928 single and multiple ascending dose study.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 86
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy volunteers
- •Age 18 - 55 years, inclusive
- •BMI 19 - 30 kilograms/meter2
- •Non-smokers or ex-smokers who ceased smoking > 3 months prior to screening visit
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
招募中
不适用
STUDY to understand the effect and tolerance of Experimental product in patient with UPPER RESPIRATORY TRACT INFECTIONS (URTI)CTRI/2021/09/036807Vedic Lifesciences Pvt Ltd
已完成
Unknown
A placebo-controlled, double-blind, randomized, comparative trial concerning body composition effected by continuously taking test food in healthy adults with mildly obese.Healthy adultsJPRN-UMIN000052822utrione Co., Ltd80
已完成
Unknown
A placebo-controlled, double-blind, randomized, comparative superiority trial concerning subjective physical symptoms effected by taking lactic acid bacteria in healthy adults.Healthy adultsJPRN-UMIN000051260IMEQRD Co., Ltd200
进行中（未招募）
1 期
A randomized, double-blind, placebo-controlled, comparative trial of AMD3100 (240 mcg/kg) plus G-CSF (10 mcg/kg) versus G-CSF (10 mcg/kg) plus placebo to mobilize and collect greater than or equal to 6x10e6 CD34+ cells/kg in multiple myeloma patients for autologous transplantation - N/AEUCTR2005-003599-39-DEAnorMED Corp.10
未知
2 期
Phase II clinical study in patients with Parkinson's disease taking L-DOPAParkinson's diseaseJPRN-jRCT2080221835Hisamitsu Pharmaceutical Co.,Inc.